Andlauer Healthcare Group Inc. (TSE:AND) Receives C$48.57 Consensus Price Target from Brokerages

Shares of Andlauer Healthcare Group Inc. (TSE:ANDGet Free Report) have received a consensus recommendation of “Moderate Buy” from the seven ratings firms that are currently covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is C$48.57.

Several equities research analysts have recently commented on AND shares. TD Securities boosted their target price on shares of Andlauer Healthcare Group from C$53.00 to C$54.00 and gave the stock a “buy” rating in a research report on Thursday, November 7th. Scotiabank lifted their price target on Andlauer Healthcare Group from C$43.00 to C$44.00 in a research note on Thursday, November 7th.

Get Our Latest Analysis on AND

Andlauer Healthcare Group Stock Performance

Shares of AND stock opened at C$43.25 on Friday. The company has a current ratio of 1.35, a quick ratio of 1.66 and a debt-to-equity ratio of 41.86. The firm has a fifty day simple moving average of C$42.15 and a two-hundred day simple moving average of C$40.23. Andlauer Healthcare Group has a 12 month low of C$36.43 and a 12 month high of C$44.92. The firm has a market capitalization of C$808.78 million, a PE ratio of 28.45 and a beta of 0.66.

About Andlauer Healthcare Group

(Get Free Report

Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.

Featured Stories

Analyst Recommendations for Andlauer Healthcare Group (TSE:AND)

Receive News & Ratings for Andlauer Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andlauer Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.